Novel mTOR inhibitors: Promising therapeutic interventions in oral cancer therapy

Oral Oncol. 2022 Oct:133:106066. doi: 10.1016/j.oraloncology.2022.106066. Epub 2022 Aug 9.

Authors

Devaraj Ezhilarasan¹, Karthik Shree Harini²

Affiliations

¹ Department of Pharmacology, Molecular Medicine and Toxicology Lab, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences (SIMATS), No.162, PH Road, Chennai, Tamil Nadu 600 077, India. Electronic address: ezhild@gmail.com.
² Department of Pharmacology, Molecular Medicine and Toxicology Lab, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamil Nadu, 600 077, India.

PMID: 35961263
DOI: 10.1016/j.oraloncology.2022.106066

No abstract available

Publication types

Letter

MeSH terms

Humans
MTOR Inhibitors*
Mouth Neoplasms* / drug therapy
Phosphoinositide-3 Kinase Inhibitors
Protein Kinase Inhibitors / therapeutic use
TOR Serine-Threonine Kinases

Substances

MTOR Inhibitors
Phosphoinositide-3 Kinase Inhibitors
Protein Kinase Inhibitors
MTOR protein, human
TOR Serine-Threonine Kinases